12 results
8-K
EX-3.1
QNCX
Quince Therapeutics Inc
5 Apr 23
Entry into a Material Definitive Agreement
5:05pm
8-K
EX-3.2
QNCX
Quince Therapeutics Inc
1 Aug 22
Quince Therapeutics Details Strategic Growth Plan with Launch of New Corporate Name
9:17am
8-K
EX-3.1
QNCX
Quince Therapeutics Inc
1 Aug 22
Quince Therapeutics Details Strategic Growth Plan with Launch of New Corporate Name
9:17am
8-K
EX-3.1
QNCX
Quince Therapeutics Inc
13 May 19
Cortexyme, Inc. Announces Pricing of Initial Public Offering
5:01pm
8-K
EX-3.2
QNCX
Quince Therapeutics Inc
13 May 19
Cortexyme, Inc. Announces Pricing of Initial Public Offering
5:01pm
S-1
EX-3.1
jl8ohb922e5f pmqb7
12 Apr 19
IPO registration
5:20pm
S-1
EX-3.3
xs7c03mi1 yuelwjznvy
12 Apr 19
IPO registration
5:20pm
DRS
EX-3.3
bc1f dkdke3x
4 Mar 19
Draft registration statement
12:00am
DRS
EX-3.1
08yt d51qag
4 Mar 19
Draft registration statement
12:00am
- Prev
- 1
- Next